Documentation of Pharmaceutical Development. Part 2. Quality System Documents

Documentation of Pharmaceutical Development. Part 2. Quality System Documents

Introduction. In the process of pharmaceutical development of a medicinal product, it is necessary to substantiate the composition of the medicinal product; develop a technology for a finished dosage form (including a primary packaging system); create documentation for various stages of product deve...

Full description

Bibliographic Details
Main Authors:	I. E. Smekhova, L. V. Shigarova, I. A. Narkevich, E. V. Flisyuk, V. D. Meteleva
Format:	Article
Language:	Russian
Published:	LLC Center of Pharmaceutical Analytics (LLC «CPHA») 2021-05-01
Series:	Разработка и регистрация лекарственных средств
Subjects:	фармацевтическая разработка фармацевтическая система качества документирование
Online Access:	https://www.pharmjournal.ru/jour/article/view/911

Similar Items

Documentation of Pharmaceutical Development. Part 1. Study of the Documentation of the Site
by: I. E. Smekhova, et al.
Published: (2021-02-01)

PROJECT-ORIENTED APPROACH TO FINISHED PHARMA PRODUCT DEVELOPMENT IN THE CONTEXT OF GENERIC POLYCOMPONENT DRUG CONTAINING AMOXYCILLIN AND CLAVULANIC ACID
by: Yu. V. Vlasenko
Published: (2019-01-01)

Application of Quality-by-Design Approach to Justify the Composition and Technology of Two-component Suppositories
by: I. E. Smekhova, et al.
Published: (2022-11-01)

PHARMACEUTICAL DEVELOPMENT OF DRUGS FOR PEDIATRIC PRACTICE: FUNDAMENTAL BASES AND SPECIFIC FEATURES
by: I. A. Narkevich, et al.
Published: (2019-01-01)

THE USE OF THE IDEF0 STANDARD IN PREPARATION FOR PHARMACEUTICAL DEVELOPMENT
by: S. A. Rozhnova, et al.
Published: (2019-01-01)

PHARMACEUTICAL DEVELOPMENT OF FORMULATION BASED ON BIOPHARMACEUTICAL PREPARATIONS FOR GENE THERAPY
by: T. V. Budylskaya, et al.
Published: (2019-01-01)

ANALYSIS OF THE SYSTEM ORGANIZATION OF PHARMACEUTICAL DRUG DEVELOPMENT
by: S. A. Rozhnova, et al.
Published: (2019-01-01)

DEVELOPMENT AND VALIDATION OF METHOD OF QUANTITATIVE DETERMINATION OF RESIDUAL ORGANIC SOLVENTS IN INNOVATIVE ACTIVE PHARMACEUTICAL INGREDIENT WITH GC-FID
by: E. V. Butina, et al.
Published: (2019-01-01)

ANALYSIS OF INDUSTRIAL PRACTICE OF DRUG QUALITY RISK MANAGEMENT IN RUSSIAN PHARMACEUTICAL ENTERPRISES
by: A. B. Kashirina, et al.
Published: (2021-03-01)

PROBLEMS AND PROSPECTS OF PHARMACEUTICAL PREVENTION IN PROFESSIONAL DISEASES
by: Андрей Георгиевич Петров, et al.
Published: (2020-07-01)

EXPLORING OF ACID-BASIC PROPERTIES, DEVELOPMENT AND VALIDATION OF THE METHOD OF QUANTITATIVE DETERMINATION OF ORIGINAL PHARMACEUTICAL SUBSTANCE
by: G. M. Alekseeva, et al.
Published: (2019-02-01)

MODELING PROCESS OF PALLIATIVE PHARMACEUTICAL CARE AS A COMPONENT OF PHARMACEUTICAL SAFETY AT THE LOCAL LEVEL
by: I. A. Tueva, et al.
Published: (2018-07-01)

BIOPHARMACEUTICAL CLASSIFICATIOM SYSTEM AS A TOOL FOR THE DEVELOPMENT OF DRUG FORMULATIONS AND THEIR DESIGNS
by: N. B. Demina
Published: (2019-01-01)

TOXICOLOGICAL AND PHARMACOLOGICAL CHARACTERISTICS OF EXCIPIENTS OF DRUG PRODUCTS OF TORASEMIDE
by: D. Yu. Ivkin, et al.
Published: (2019-01-01)

DRUGS EFFICIENCY AND SAFETY: THE ROLE OF PHARMACEUTICAL INDUSTRY
by: F. I. Belyalov
Published: (2015-09-01)

USE OF DISSOLUTION TEST FOR EVALUATION OF PHARMACEUTICAL EQUIVALENCE OF ATORVASTATIN GENERICS
by: O. V. Druzhininskaya, et al.
Published: (2019-01-01)

Search of ways of pharmaceutical enterprises taxation optimization
by: Z. K. Drugova
Published: (2003-06-01)

The Use of Digital Technologies for the Purpose of Improving Methodological Approaches to the Creation of a Pharmaceutical Quality System at Enterprises for the Production of Medicines
by: V. V. Goryachkin, et al.
Published: (2021-11-01)

STANDARDIZATION OF CATIONIC DERIVATIVE OF BAKTERIOPURPURINIMID AS PHARMACEUTICAL SUBSTANCE FOR ANTIMICROBIAL PHOTODYNAMIC THERAPYA
by: A. M. Frolova, et al.
Published: (2019-01-01)

III International Scientific and Practical Conference «Harmonization of approaches to pharmaceutical development», Held on November 25, 2020
by: Article Editorial
Published: (2020-12-01)

Comparative Analysis of the QbD Approach in the Pharmaceutical Industry
by: S. A. Rozhnova, et al.
Published: (2019-11-01)

Complex assessment of the main characteristics of scientific information and methods of its obtaining for pharmaceutical workers
by: A V Lobuteva, et al.
Published: (2015-12-01)

Guidelines for Promoting the Implementation of Pharmaceutical Quality Systems at EAEU Enterprises Through the Management of the Engagement of Production Personnel
by: V. A. Smirnov, et al.
Published: (2021-02-01)

Designing of electronic terminological dictionary on pharmaceutical chemistry
by: O E Sattarova
Published: (2010-12-01)

DEVELOPMENT OF THE STANDARD FOR EDUCATION OF THE SPECIALIST FOR CONTROL AND TESTING THE QUALITY OF NANOSTRUCTURED PHARMACEUTICALS
by: S. A. Kedik, et al.
Published: (2019-01-01)

Methodic approaches to prediction of a positive corporate image of pharmaceutical organizations
by: A. G. Petrov, et al.
Published: (2010-02-01)

FORMATION OF REQUIREMENTS TO SPECIALIST-EXPLORER IN DEVELOPMENT OF RECEIPT OF NANOSTRUCTURED PHARMACEUTICALS
by: S. A. Kedik, et al.
Published: (2019-01-01)

PHARMACEUTICAL SERVICES: STATUS AND DEVELOPMENT TRENDS
by: A. A. Klimenkova, et al.
Published: (2021-06-01)

Standardization of the Pharmaceutical Substance of the Drug LCS-1208
by: E. V. Ignateva, et al.
Published: (2021-08-01)

CONCEPT OF MEDICAL AND PHARMACEUTICAL CARE FOR MYOCARDIAL INFARCTION AS A PROSPECTIVE FORM OF SERVICE TO THE POPULATION
by: Андрей Георгиевич Петров, et al.
Published: (2021-04-01)

ANALYSIS OF THE PERSONNEL POTENTIAL EFFICIENCY OF THE PHARMACEUTICAL INSTITUTION
by: Марина Юрьевна Клищенко, et al.
Published: (2017-03-01)

The results of sociological research to improve the quality of pharmaceutical care
by: E A Mikhailova, et al.
Published: (2013-12-01)

ACTIVE SUBSTANCES FOR DOMESTIC MANUFACTURER OF MEDICINES: PAST, PRESENT AND FUTURE
by: K. O. Sidorov, et al.
Published: (2019-01-01)

Technologic Considerations of Creation Dosage Form of Original Substance 3,7-diazabicyclo[3.3.1]nonane
by: G. E. Brkich, et al.
Published: (2020-11-01)

Development and Biopharmaceutical Evaluation of Tablets Based on the Poorly Water-soluble Substance 1-[2-(2-benzoylphenoxy)ethyl]-6-methyluracil
by: D. V. Demchenko, et al.
Published: (2020-11-01)

ASSESSMENT OF QUALITY OF GENERICS IN CARDIOLOGY: REALITY AND POSSIBILITIES
by: V. V. Yakusevich
Published: (2015-12-01)

Quality assessment of pharmaceutical care to patients with headaches using the simulated patient method: drug recommendations and pharmaceutical counseling
by: O. V. Reshetko, et al.
Published: (2023-07-01)

THE RELEVANCE OF THE DEVELOPMENT AND IMPLEMENTATION OF MEDICAL AND PHARMACEUTICAL CULTURE AS A BASIS FOR THE PREVENTION OF OCCUPATIONAL DISEASES
by: Андрей Георгиевич Петров, et al.
Published: (2021-11-01)

Factor analysis of profit wholesale-retail pharmaceutical companies
by: I. A. Nechepurenko, et al.
Published: (2016-06-01)

TECHNOLOGICAL BASIS FOR THE CREATION OF IMPLANTS WITH A PHARMACEUTICAL COMPOSITION OF CIPROFLOXACIN AND THEIR ANTIMICROBIAL ACTIVITY IN EXPERIMENTS IN VITRO
by: V. V. Sheykin, et al.
Published: (2016-06-01)